Focused Wealth Management, Inc - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260706. A total of 2 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Focused Wealth Management, Inc ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2022$0700
+133.3%
0.00%
Q4 2021$03000.0%0.00%
Q3 2021$03000.0%0.00%
Q2 2021$03000.0%0.00%
Q1 2021$0300
-40.0%
0.00%
Q4 2020$05000.0%0.00%
Q3 2020$05000.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q2 2022
NameSharesValueWeighting ↓
Virtu Financial LLC 94,039$79,0000.01%
GSA CAPITAL PARTNERS LLP 79,001$66,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 264,500$222,0000.01%
Squarepoint Ops LLC 311,867$262,0000.00%
Orion Portfolio Solutions, LLC 79,542$67,0000.00%
FCG ADVISORS, LLC 10,600$9,0000.00%
Summit Global Investments 20,000$17,0000.00%
IFP Advisors, Inc 11,966$10,0000.00%
Sowell Financial Services LLC 15,000$13,0000.00%
NEXT Financial Group, Inc 5$00.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders